Aromatase Explains Why Testosterone Increases Breast Cancer Rate

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-09-0157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Forskolin Increases the Effect of Everolimus on Aromatase Inhibitor-Resistant Breast Cancer Cells

Oncotarget
Oncology
2018English

Estrone Sulphate, FSH, and Testosterone Levels in Two Male Breast Cancer Patients Treated With Aromatase Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2010English

Aromatase and Breast Cancer: W39R, an Inactive Protein

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2002English

Genetic Variants of CYP19 (Aromatase) and Breast Cancer Risk

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Aromatase and COX in Breast Cancer: Enzyme Inhibitors and Beyond

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2007English

Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor

Breast Care
SurgeryOncology
2010English

Effects of Aromatase Inhibition vs. Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial

Andrology
EndocrinologyReproductive MedicineUrologyMetabolismDiabetes
2015English

Error in Breast Cancer Detection Rate

JAMA Oncology
Cancer ResearchOncology
2016English

Profiles of miRNAs Matched to Biology in Aromatase Inhibitor Resistant Breast Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy